Tradestie Institutional Equity Comparison Engine
EQ vs CABA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EQ Overall Edge
EQ Captures Institutional Edge (3โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Momentum & Technical, Options & Structure. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus CABA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against CABA sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
EQ
EQ 1.5x vs CABA N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -52.3% vs +0.0%
Momentum & Technical Winner
EQ
1Y +12.0% vs -56.8% ยท 52W Pos 11% vs 1%
Options & Structure Winner
EQ
UNCLASSIFIED (100th %ile IV) vs BREAKDOWN (32nd %ile IV)
EQ
NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap
$90.6M
1M Return
-21.13%
1Y Return
+12.0%
Forward P/E
1.5x
Unified AI Score
48.0 / 100
HOLD
Tech 30.0
Fund 51.0
Flow 63.0
Mom 60.0
CABA
NASDAQ
Cabaletta Bio, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.01
-4.27% 1D
Market Cap
$227.6M
1M Return
-34.42%
1Y Return
-56.84%
Forward P/E
N/M
Unified AI Score
46.9 / 100
HOLD
Tech 35.0
Fund 51.0
Flow 64.0
Mom 59.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
EQ +12.0%
CABA -56.84%
Spread: +68.84 pp (EQ Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
EQ TTM Op. Margin: 0.0%
CABA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EQ vs CABA. Trailing 12-month operating profitability (EQ 0.0% vs CABA 0.0%) and valuation multiples (EQ 1.5x vs CABA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | EQ | CABA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $90.6M | $227.6M | Larger Scale | CABA |
| Trailing P/E Ratio Valuation | 1.5x | N/M | Lower Multiple | EQ |
| Forward P/E Ratio Valuation | 1.5x | N/M | Lower Multiple | EQ |
| Revenue Growth (YoY) Growth | -52.3% | +0.0% | Higher Growth | CABA |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -59.0% | -89.5% | Higher ROE | EQ |
| 52-Week Range Position Momentum | 11% ($1โ$4) | 1% ($1โ$4) | Stronger Trend | EQ |
| Beta / 30D Volatility Risk Regime | 1.53ฮฒ ยท 93% Vol | 1.94ฮฒ ยท 102% Vol | Lower Realized Risk | EQ |
| Unified Institutional Score Composite Signal | 48.0 / 100 (HOLD) | 46.9 / 100 (HOLD) | Higher Composite | EQ |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full EQ vs CABA Buy Guide
EQ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
CABA
BREAKDOWN
138d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
32nd %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither EQ nor CABA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.